Jeffrey Spaw, MD
Orthopaedic Surgery · College Station, TXNPI 1740239979
Payments from drug & device makers
Across 30 payments — averaging $156.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Encore Medical, LP$3K
- Medinc Of Texas$1K
- Smith+Nephew$173
- Medical Device Business Services, Inc.$44
- Treace Medical Concepts, Inc.$42
- Next Science LLC$34
- plus $226 from 11 others
What the payments were for
- Speaking & faculty fees$1,50032%
- Travel & lodging$1,29728%
- Food & beverage$71815%
- Education$1,17425%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Encore Medical, LP | 5 | $2,849 |
| Medinc Of Texas | 3 | $1,320 |
| Smith+Nephew | 4 | $173 |
| Medical Device Business Services, Inc. | 2 | $44 |
| Treace Medical Concepts, Inc. | 2 | $42 |
| Next Science LLC | 1 | $34 |
| Johnson & Johnson | 2 | $32 |
| Endo Pharmaceuticals Inc. | 2 | $30 |
| Vertex | 1 | $26 |
| Stryker | 1 | $22 |
| Vericel Corporation | 1 | $22 |
| Pacira Pharmaceuticals Incorporated | 1 | $18 |
| Heron Therapeutics, Inc. | 1 | $18 |
| Kowa Pharmaceuticals America, Inc. | 1 | $17 |
| Amgen | 1 | $15 |
| Acell, Inc. | 1 | $14 |
| AstraZeneca | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DJO Surgical TaperFill Hip System$1,500
- DJO Surgical Exprt Revision Hip$1,500
- DJO Surgical Empowr Knee System$1,500
- DJO Surgical 3DKnee System$1,297
- Grafix PRIME$123
- Grafix CORE$123
- Grafix XC$123
- Grafix PL PRIME$123
- Stravix$123
How this compares
$4,689 in reported general payments places this provider in the 45th percentile of 1,337 orthopaedic surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 92 | $3,043 |
| Meloxicam | 496 | $1,802 |
| Cephalexin | 135 | $1,562 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 121 | $994 |
| Tramadol Hcl | 146 | $558 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 53 | $502 |
| Naproxen | 42 | $403 |
| Ketorolac Tromethamine | 14 | $226 |
| Methylprednisolone | 27 | $193 |
| Diclofenac Sodium | 16 | $186 |
| Clindamycin Hcl | 21 | $100 |
| Hydromorphone Hcl | 12 | $54 |
| Levofloxacin | 12 | $36 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in College Station
- Stephen BurkhartSan Antonio$185.3M
- Kirby HittTemple$9.1M
- J Richard EvansonPlano$8.1M
- Stefan KreuzerHouston$7M
- Robert GrahamAustin$6.3M
- Richard JonesDallas$6.3M
- Howard HarrisBedford$4.6M
- Tiffany HuynhHouston$4.6M
- Michael WirthSan Antonio$4.5M
- Stephen IncavoHouston$4.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.